Full metadata record
DC FieldValueLanguage
dc.creatorMilagro-Yoldi, F.I. (Fermín Ignacio)-
dc.creatorMansego-Talavera, M.L. (María Luisa)-
dc.creatorMiguel-Vázquez, C. (Carlos) de-
dc.creatorMartinez, J.A. (José Alfredo)-
dc.date.accessioned2013-03-06T17:24:12Z-
dc.date.available2013-03-06T17:24:12Z-
dc.date.issued2012-
dc.identifier.citationMilagro FI, Mansego-Talavera ML, De Miguel C, Martínez JA. Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives. Mol Aspects Med (0).es_ES
dc.identifier.issn0098-2997-
dc.identifier.urihttps://hdl.handle.net/10171/28106-
dc.description.abstractNutritional factors play a life-long role in human health. Indeed, there is growing evidence that one of the mechanisms by which nutrients and bioactive compounds affect metabolic traits is epigenetics. Complex interactions among food components and histone modifications, DNA methylation, non-coding RNA expression and chromatin remodeling factors lead to a dynamic regulation of gene expression that controls the cellular phenotype. Although perinatal period is the time of highest phenotypic plasticity, contributing largely to developmental programming, also during adulthood there is evidence about a nutritional influence on epigenetic regulation. Similarly to type 2 diabetes, hypertension, atherosclerosis and other metabolic disorders, obesity predisposition and weight loss outcomes have been repeatedly associated to changes in epigenetic patterns. Different non-nutritional risk factors that usually accompany obesity seem also to be involved in these epigenetic modifications, especially hyperglycemia, inflammation, hypoxia and oxidative stress. There are currently three major objectives in epigenetic research in relation to obesity: to search for epigenetic biomarkers to predict future health problems or detect the individuals at most risk, to understand the obesity-related environmental factors that could modulate gene expression by affecting epigenetic mechanisms, and to study novel therapeutic strategies based on nutritional or pharmacological agents that can modify epigenetic marks. At this level, the major tasks are: development of robust epigenetic biomarkers of weight regulation, description of those epigenetic marks more susceptible to be modified by dietary exposures, identification of the active ingredients (and the doses) that alter the epigenome, assessment of the real importance of other obesity-related factors on epigenetic regulation, determination of the period of life in which best results are obtained, and understanding the importance of the inheritance of these epigenetic marks.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectHistone modificationses_ES
dc.subjectDNA methylationes_ES
dc.subjectHyperglycemiaes_ES
dc.subjectInflammationes_ES
dc.subjectOxidative stresses_ES
dc.subjectHypoxiaes_ES
dc.subjectPolyphenolses_ES
dc.subjectEpigenetic biomarkerses_ES
dc.titleDietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectiveses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttp://dx.doi.org/10.1016/j.mam.2012.06.010es_ES

Files in This Item:
Thumbnail
File
Molecular Aspects of Medicine Milagro et al-1.pdf
Description
Size
357.31 kB
Format
Adobe PDF
Thumbnail
File
MolAspMedTable 1.pdf
Description
Size
75.76 kB
Format
Adobe PDF
Thumbnail
File
MolAspMedTable 2.pdf
Description
Size
27.68 kB
Format
Adobe PDF
Thumbnail
File
MolAspMedFigures.pdf
Description
Size
226.66 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.